The EPS projection of Rosetta Stone (NYSE:RST) for quarter ended 2016-09-30 is $-0.55. Last week, the projection for EPS was $-0.55 against target of $-0.55, a month earlier. While 2-months ago, this projection was $-0.55 versus forecast of $-0.55a quarter months earlier, posting a deviation of 0%.
Rosetta Stone (NYSE:RST) posted that 18 days earlier, the share price was revised 0 times on upside. In addition, negative revisions were 1.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 0, and 0, correspondingly.
The per-share earnings downgrade for Rosetta Stone (NYSE:RST) in the preceding 30 and 120 were 0 and 1. While in 60 and 90 days were 0, and 2, in that order.
Rosetta Stone (NYSE:RST) EPS target was $-0.55 for the quarter closed 1. It was based on 2 calls. As on 2016-05-04 the EPS was $-0.22. The change was $0.3, posting a deviation of 57.69%. The price projections gave a standard deviation of 0.03.
Quarterly Sales Estimates
Rosetta Stone (NYSE:RST) sales prediction for the fiscal 2016 stands at $49.06 and the median estimate is at $49.06. Almost 2 analysts gave sales target.
Among this, the highest sales estimate is $49.5 while the lowest target is $48.62 showing standard deviation of 0.622%.
As many as 2 analysts have positive sales targets revision while 2 reduced sales estimates, posting a deviation of 0%.
Last month, 2 experts have positive sales number revision. Also, 2 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast, posting a deviation of -9.181%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...